A detailed history of Meeder Advisory Services, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Meeder Advisory Services, Inc. holds 10,341 shares of OGN stock, worth $155,735. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,341
Previous 10,864 4.81%
Holding current value
$155,735
Previous $225 Million 12.03%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$18.65 - $23.03 $9,753 - $12,044
-523 Reduced 4.81%
10,341 $198 Million
Q2 2024

Aug 08, 2024

BUY
$17.45 - $21.96 $189,576 - $238,573
10,864 New
10,864 $225 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.83B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Meeder Advisory Services, Inc. Portfolio

Follow Meeder Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Meeder Advisory Services, Inc. with notifications on news.